![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/12/2862147/0/en/Portage-Biotech-Announces-Plans-to-Expand-its-Evaluation-of-Strategic-Alternatives.html
https://www.globenewswire.com/news-release/2024/03/26/2852321/0/en/Portage-Biotech-Completes-Monetization-of-Intensity-Therapeutics-INTS-shares.html
https://www.globenewswire.com//news-release/2024/02/28/2837515/0/en/Portage-Biotech-Reports-Results-for-Fiscal-Quarter-Ended-December-31-2023-and-Business-Update.html
https://www.globenewswire.com//news-release/2024/01/04/2803981/0/en/Portage-Biotech-Reports-Business-and-Strategic-Update.html
https://www.globenewswire.com//news-release/2023/11/28/2787342/0/en/Portage-Biotech-Reports-Results-for-Fiscal-Quarter-Ended-June-30-2023-and-Business-Update.html
https://www.globenewswire.com//news-release/2023/11/06/2774085/0/en/Portage-Biotech-Presents-Updates-on-its-iNKT-and-Adenosine-programs-at-the-Society-for-Immunotherapy-of-Cancer-s-SITC-38th-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/09/29/2751954/0/en/Portage-Biotech-Announces-6-0-Million-Registered-Direct-Offering.html
https://www.globenewswire.com//news-release/2023/09/20/2746389/0/en/Portage-Biotech-to-Participate-in-Panel-Discussion-at-the-Cantor-Global-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/09/05/2737299/0/en/Portage-Biotech-Announces-Collaboration-with-Merck-to-Evaluate-Two-Next-Generation-Adenosine-Antagonists-in-Combination-with-KEYTRUDA-Pembrolizumab-in-Solid-Tumors.html
https://www.globenewswire.com//news-release/2023/08/30/2734287/0/en/Portage-Biotech-Reports-Results-for-Fiscal-Quarter-Ended-June-30-2023-and-Business-Update.html